BioSpace News Archive

Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, today announced that a new peer-reviewed study demonstrates the utility of incorporating Remote Electrical Neuromodulation (REN) into usual care of chronic migraine.

Eloxx Pharmaceuticals, Inc., (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis and other diseases caused by nonsense mutations limiting production of functional proteins, today announced that a scientific manuscript titled: “ELX-02 Generates Protein via Premature Stop Codon Read-through Without Inducing Native Stop Codon Read-through Protein”

Funding will support CDC Foundation collaboration with the Centers for Disease Control and Prevention to prevent the deadly tick-borne disease

BioAegis Therapeutics Inc., announces that it received regulatory clearance from The Spanish Agency for Medicines and Health Products (AEMPS) for its Phase 2 Proof of Concept study of its lead product, recombinant human plasma gelsolin (rhu-pGSN) in hospitalized patients with severe COVID-19 pneumonia.

Stronger growth and higher profitability expected for the Bioprocess Solutions Division and the entire Group; outlook for the Lab Products & Services Division unchanged

Based on strong business performance in the first half of 2020 and on expectations that demand will remain high for the rest of the year, Sartorius Stedim Biotech is raising its growth and earnings forecast for fiscal 2020.

HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”) today announced the closing of the underwritten public offering of an additional 690,000 shares of its common stock pursuant to the exercise in full by the underwriters of their over-allotment option

Two scientific papers published in today’s online issue of Nature mark a dramatic step forward in our understanding of the cellular details of aging.

LifeLabs is proud to announce that it is launching WorkClear, an evidence-based approach to help Canadian companies bring employees safely back to work as the Canadian economy begins to re-open.

Qosina is pleased to announce they have teamed up with veteran medical adhesive manufacturer H.B. Fuller to offer a selection of off-the-shelf instant and UV-curable cyanoacrylate adhesive solutions for bonding medical device assemblies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200715005817/en/ Qosina adds instant and UV-curable adhesives to its